Somantadine (INN ; developmental code name PR 741-976), or somantadine hydrochloride (USAN ) in the case of the hydrochloride salt, is an experimental antiviral drug of the adamantane family related to amantadine and rimantadine that was never marketed.[1][2][3] It was first described by 1978.[1]
Clinical data | |
---|---|
Other names | PR 741-976; a,a-Dimethyl-1-adamantaneethylamine; [2-(1-Adamantyl)-1,1-dimethylethyl]amine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H25N |
Molar mass | 207.361 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ a b Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 2. ISBN 978-1-4757-2085-3. Retrieved 13 September 2024.
- ^ Milne GW (2017). Ashgate Handbook of Anti-Infective Agents: An International Guide to 1, 600 Drugs in Current Use: An International Guide to 1, 600 Drugs in Current Use. Routledge Revivals. Taylor & Francis. p. 294. ISBN 978-1-351-73490-5. Retrieved 13 September 2024.
- ^ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akademie Verlag. p. 943. ISBN 978-3-05-500156-7. Retrieved 13 September 2024.